Wafik Mohamed, Taylor John, Lester Tracy, Gibbons Richard J, Shears Deborah J
Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Eur J Med Genet. 2018 May;61(5):273-279. doi: 10.1016/j.ejmg.2018.01.002. Epub 2018 Jan 4.
Pontocerebellar hypoplasia type 10 (PCH10) is a progressive autosomal recessive neurodegenerative disorder that has been recently described in association with cleavage and polyadenylation factor I subunit 1 (CLP1) mutations. To date, all reported cases have the same homozygous missense mutation in the CLP1 gene suggesting a founder mutation. CLP1 is an RNA kinase involved in tRNA splicing and maturation. There is evidence that the mutation is associated with functionally impaired kinase activity and subsequent defective tRNA processing. Through whole exome sequencing, we identified the same mutation in an extended family of Turkish origin. Both children presented with severe psychomotor delay, progressive microcephaly, and constipation. However, intrafamilial phenotypic variability is suggested due to the variability in their brain abnormalities and clinical features.
10型脑桥小脑发育不全(PCH10)是一种进行性常染色体隐性神经退行性疾病,最近被描述与切割和聚腺苷酸化因子I亚基1(CLP1)突变有关。迄今为止,所有报道的病例在CLP1基因中都有相同的纯合错义突变,提示存在奠基者突变。CLP1是一种参与tRNA剪接和成熟的RNA激酶。有证据表明,该突变与激酶活性功能受损以及随后的tRNA加工缺陷有关。通过全外显子组测序,我们在一个来自土耳其的大家庭中发现了相同的突变。两个孩子均表现出严重的精神运动发育迟缓、进行性小头畸形和便秘。然而,由于他们大脑异常和临床特征的变异性,提示存在家族内表型变异性。